Hypera S.A. (HYPE3.SA)
BRL 16.8
(-5.46%)
BRL 16.8
(-5.46%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 2.28 Billion BRL | -6.53% |
| 2022 | 2.64 Billion BRL | 29.78% |
| 2021 | 2.03 Billion BRL | 45.62% |
| 2020 | 1.39 Billion BRL | 28.8% |
| 2019 | 1.08 Billion BRL | -11.72% |
| 2018 | 1.22 Billion BRL | 6.02% |
| 2017 | 1.15 Billion BRL | 8.51% |
| 2016 | 1.06 Billion BRL | 20.94% |
| 2015 | 883.86 Million BRL | -2.88% |
| 2014 | 910.08 Million BRL | 1.51% |
| 2013 | 896.55 Million BRL | 16.35% |
| 2012 | 770.58 Million BRL | 83.03% |
| 2011 | 421 Million BRL | -31.2% |
| 2010 | 611.95 Million BRL | 31.74% |
| 2009 | 464.53 Million BRL | 65.46% |
| 2008 | 280.75 Million BRL | 471.81% |
| 2007 | 49.1 Million BRL | 937.17% |
| 2006 | -5.86 Million BRL | -117.46% |
| 2005 | 33.6 Million BRL | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 561.99 Million BRL | 6.69% |
| 2024 Q2 | 646.94 Million BRL | 22.28% |
| 2023 Q3 | 777.06 Million BRL | 1.24% |
| 2023 Q1 | 572.21 Million BRL | -22.67% |
| 2023 FY | 2.47 Billion BRL | -6.53% |
| 2023 Q2 | 767.52 Million BRL | 34.13% |
| 2023 Q4 | 526.74 Million BRL | -32.21% |
| 2022 Q1 | 500.15 Million BRL | -11.58% |
| 2022 Q2 | 681.83 Million BRL | 36.33% |
| 2022 Q3 | 720.66 Million BRL | 5.7% |
| 2022 Q4 | 739.97 Million BRL | 2.68% |
| 2022 FY | 2.64 Billion BRL | 29.78% |
| 2021 Q3 | 568.53 Million BRL | 0.13% |
| 2021 FY | 2.03 Billion BRL | 45.62% |
| 2021 Q1 | 336.16 Million BRL | 6.82% |
| 2021 Q2 | 567.77 Million BRL | 68.9% |
| 2021 Q4 | 565.64 Million BRL | -0.51% |
| 2020 FY | 1.39 Billion BRL | 28.8% |
| 2020 Q2 | -15.71 Million BRL | -106.39% |
| 2020 Q1 | 245.94 Million BRL | -77.12% |
| 2020 Q4 | 314.71 Million BRL | -17.38% |
| 2020 Q3 | 380.94 Million BRL | 2523.45% |
| 2019 Q4 | 1.07 Billion BRL | 11925.73% |
| 2019 Q1 | 371.43 Million BRL | 22.09% |
| 2019 Q3 | 8.93 Million BRL | -96.66% |
| 2019 Q2 | 267.54 Million BRL | -27.97% |
| 2019 FY | 1.08 Billion BRL | -11.72% |
| 2018 Q3 | 2.64 Billion BRL | 711.03% |
| 2018 Q1 | 342.89 Million BRL | 35.4% |
| 2018 FY | 1.22 Billion BRL | 6.02% |
| 2018 Q4 | 304.24 Million BRL | -88.51% |
| 2018 Q2 | 326.59 Million BRL | -4.75% |
| 2017 Q3 | 273.7 Million BRL | -8.92% |
| 2017 Q2 | 300.49 Million BRL | -9.64% |
| 2017 Q1 | 332.55 Million BRL | 36.62% |
| 2017 FY | 1.15 Billion BRL | 8.51% |
| 2017 Q4 | 253.24 Million BRL | -7.48% |
| 2016 Q3 | 240.39 Million BRL | -17.19% |
| 2016 FY | 1.06 Billion BRL | 20.94% |
| 2016 Q4 | 243.41 Million BRL | 1.26% |
| 2016 Q2 | 290.29 Million BRL | -1.55% |
| 2016 Q1 | 294.87 Million BRL | 56.2% |
| 2015 Q2 | 234.59 Million BRL | 2.19% |
| 2015 Q3 | 230.91 Million BRL | -1.57% |
| 2015 Q4 | 188.78 Million BRL | -18.25% |
| 2015 FY | 883.86 Million BRL | -2.88% |
| 2015 Q1 | 229.56 Million BRL | 15.4% |
| 2014 Q1 | 218.65 Million BRL | -16.38% |
| 2014 Q4 | 198.91 Million BRL | -19.57% |
| 2014 Q3 | 247.32 Million BRL | 0.87% |
| 2014 FY | 910.08 Million BRL | 1.51% |
| 2014 Q2 | 245.19 Million BRL | 12.14% |
| 2013 Q3 | 221.9 Million BRL | -0.24% |
| 2013 Q2 | 222.42 Million BRL | 16.6% |
| 2013 Q1 | 190.75 Million BRL | -12.49% |
| 2013 FY | 896.55 Million BRL | 16.35% |
| 2013 Q4 | 261.47 Million BRL | 17.83% |
| 2012 Q4 | 217.97 Million BRL | 7.77% |
| 2012 Q1 | 143.8 Million BRL | 235.4% |
| 2012 Q2 | 206.56 Million BRL | 43.65% |
| 2012 Q3 | 202.24 Million BRL | -2.09% |
| 2012 FY | 770.58 Million BRL | 83.03% |
| 2011 Q4 | 42.87 Million BRL | -14.61% |
| 2011 Q1 | 149.88 Million BRL | -11.26% |
| 2011 FY | 421 Million BRL | -31.2% |
| 2011 Q2 | 178.04 Million BRL | 18.79% |
| 2011 Q3 | 50.21 Million BRL | -71.8% |
| 2010 FY | 611.95 Million BRL | 31.74% |
| 2010 Q3 | 150.25 Million BRL | 13.77% |
| 2010 Q2 | 132.06 Million BRL | -13.09% |
| 2010 Q4 | 168.89 Million BRL | 12.4% |
| 2010 Q1 | 151.95 Million BRL | 4.32% |
| 2009 Q2 | 103.63 Million BRL | 14.3% |
| 2009 Q1 | 90.66 Million BRL | 0.0% |
| 2009 FY | 464.53 Million BRL | 65.46% |
| 2009 Q4 | 145.66 Million BRL | 17.11% |
| 2009 Q3 | 124.38 Million BRL | 20.03% |
| 2008 FY | 280.75 Million BRL | 471.81% |
| 2007 FY | 49.1 Million BRL | 937.17% |
| 2006 FY | -5.86 Million BRL | -117.46% |
| 2005 FY | 33.6 Million BRL | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Blau Farmacêutica S.A. | 211.53 Million BRL | -980.301% |